# Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

> **NCT01293461** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cebix Incorporated** · enrollment: 72 (actual)

## Conditions studied

- Type 1 Diabetes
- Diabetes Mellitus
- Peripheral Diabetic Neuropathy

## Interventions

- **DRUG:** CBX129801
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01293461
- **Lead sponsor:** Cebix Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293461, "Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01293461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*